Squamous Cell Carcinoma
New findings reported from A. Lopezalbaitero and co-authors describe advances in squamous cell carcinoma
Published in Cancer Weekly, October 20th, 2009
"Immunotherapy with the EGFR-specific mAb cetuximab is clinically effective in 10-20% of patients with squamous cell carcinoma of the head and neck (SCCHN). Little information is available about the mechanism(s) underlying patients' differential clinical response to cetuximab-based immunotherapy, although this information may contribute to optimizing the design of cetuximab-based immunotherapy," scientists in the United States report.
"Our understanding of these mechanisms would benefit from the characterization of the variables which influence the extent of cell dependent-lysis of SCCHN cells incubated with cetuximab in vitro. Therefore, in this study we have...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2009-10-20)
More Articles from Cancer Weekly
- Wiley-Blackwell
Stem cells which 'fool immune system' may provide vaccination for cancer - AngioDynamics
AngioDynamics Reports Fiscal First Quarter 2010 Financial Results - Baron & Budd
Dr. Deborah Morosini, M.D. Speaks Out on Lung Cancer and Asbestos in National Campaign - BC Cancer Foundation
Major breast cancer breakthrough announced at BC Cancer Agency - Cancer Gene Therapy
New cancer gene therapy research from K.J. Zhang and co-researchers described - Cancer Gene Therapy
New cancer gene therapy study findings have been reported by S.M.B. Fong and colleagues - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
